Desmond Lynch
Analyst · SIG
Thank you, Luc. I'd like to begin with a summary of our financial results for the third quarter on Slide 5. Once again, we delivered a strong quarter with our financial results above the high end of both our revenue and earnings expectations and generated a quarterly record cash from operations of $80 million. Our ability to consistently generate strong cash flows has enabled us to invest in our strategic initiatives and consistently return capital to shareholders. During the quarter, we initiated a $100 million accelerated share repurchase program which immediately retired 3.1 million shares. In addition, we paid a net amount of $54 million to repurchase $39 million aggregated principal amount of our convertible notes. Let me walk you through our non-GAAP income statement on Slide 6. We continue to execute and revenue for the third quarter was $112.2 million, above the high end of our expectations. Royalty revenue was $29.9 million, in line with our expectations. It was down from the prior quarter due to upfront revenue for several license arrangements being included in Q2. Licensing billings was $62.2 million. The difference between licensing billings and royalty revenue primarily relates to timing as we do not always recognize revenue in the same quarter as we bill our customers. Product revenue was $58.6 million, consisting primarily of memory interface chips. Memory interface chip revenue was a record for the company and we are delighted to see such strong demand from our customers. Contract and other revenue was $23.7 million consisting primarily of silicon IP. As a reminder, only a portion of our silicon IP revenue is reflected in contract and other revenue and the remaining portion is reported in royalty revenue as well as in licensing billings. Total operating costs, including cost of goods sold for the quarter was $77.9 million. Operating expenses of $54.6 million were in line with our expectations and we ended the quarter with a total head count of 763 employees. Under ASC 606, we recorded $1.2 million of interest income related to the financing component of fixed fee licensing arrangements for which we have recognized revenue but not yet received payment. Additionally, we benefited from approximately $1.7 million in favorable foreign currency exchanges during the period. We incurred approximately $100,000 of interest expense associated with our convertible notes. This was offset by incremental interest income associated with our cash and investment portfolio. And adjusting for noncash interest expense on the convertible notes, this resulted in non-GAAP interest and other income for the third quarter of $2.9 million. Excluding the financing interest income related to ASC 606, this would have been $1.6 million of interest and other income. Using an assumed flat tax rate of 24%, non-GAAP pretax income for the quarter was $28.3 million. With disciplined execution and focus, we delivered earnings that were above the high end of our expectations. Now, let me turn to the balance sheet details on Slide 7. We ended the quarter with cash, cash equivalents and marketable securities totaling $264.8 million down from the previous quarter as record cash from operations of $80 million was offset by the $100 million accelerated share repurchase program we initiated in the quarter and $54 million net payment to repurchase the convertible notes. At the end of Q3, we now have approximately $10 million in aggregated principal amount remaining of our convertible notes which are due to mature in February 2023. As we continue to execute, we expect to deliver strong cash from operations in the future. At the end of Q3, we had contract assets worth $180 million which reflects the net present value of unbilled accounts receivable related to licensing arrangements for which the company has no future performance obligations. We expect this number to continue to trend down as we bill and collect for these contracts. It is important to note that this metric does not represent the entire value of our existing licensing agreements as with each renewal opportunity, we restructure our patent agreements in a manner that allows us to recognize revenue each quarter. Third quarter CapEx was $9.3 million, while depreciation expense was $6.7 million. We delivered $70.7 million [ph] of free cash flow in the quarter. Looking forward, we expect CapEx for the fourth quarter to be approximately $8 million. As a reminder, the forward-looking guidance reflects our current best estimates at this time and our actual results could differ materially from what I'm about to review. In addition to the financial outlook under ASC 606, we've also been providing information on licensing billings which is an operational metric that reflects amounts invoiced to our licensing customers during the period adjusted for certain differences. As we have reported historically, licensing billings closely correlates with what we had historically reported as royalty revenue under ASC 605. Now, let me turn to our guidance for the fourth quarter on Slide 8. Under ASC 606, we expect revenue in the fourth quarter between $119 million and $125 million. We expect royalty revenue between $29 million and $35 million and licensing billings between $59 million and $65 million. We expect Q4 non-GAAP total operating costs which includes COGS to be between $86 million and $82 million. Under ASC 606, non-GAAP operating results for the fourth quarter is expected to be between a profit of $33 million and $43 million. For non-GAAP interest and other income and expense which excludes interest income related to ASC 606, we expect approximately $500,000 of interest expense. We expect the pro forma tax rate to remain at approximately 24%. The 24% is higher than the statutory tax rate of 21%, primarily due to higher tax rates in our foreign jurisdictions. As a reminder, we pay approximately $20 million of cash taxes each year, driven primarily by licensing agreements with our partners in Korea. We expect non-GAAP taxes to be between an expense of $8 million and $10 million in Q4. We expect Q4 share count to be 110 million basic and diluted shares outstanding. Overall, we anticipate a non-GAAP earnings per share range between $0.22 and $0.29 for the quarter. Let me finish with a summary on Slide 9. I am pleased with our excellent results and the team's execution in this macroeconomic environment. Our strategy is paying off and we have a diversified portfolio fueled by continued product revenue growth in memory interface chips, sustained momentum in silicon IP and the stable backbone of our licensing business. We were pleased to announce we extended our licensing agreement with Samsung for an additional 10 years in substantially the same financial terms which demonstrates the continued strength and relevance of our patent portfolio and innovation engine. I'm really pleased that when this extension comes into effect in Q4 2023, we expect to account for this agreement to be recognized quarterly under ASC 606. With continued discipline and focus, we are now well positioned to execute on our long-term strategic plans. We continue to grow the business profitably with strong cash generation and minimal debt which has enabled consistent capital returns to our shareholders. Before I open the call up to Q&A, I would like to thank our employees for their continued teamwork and execution. With that, I'll turn the call back to our operator to begin Q&A. Could we have our first question?